Dystrophin Expressing Chimeric (DEC) Cell Therapy for Duchenne Muscular Dystrophy: A First-in-Human Study with Minimum 6 Months Follow-up
Titel:
Dystrophin Expressing Chimeric (DEC) Cell Therapy for Duchenne Muscular Dystrophy: A First-in-Human Study with Minimum 6 Months Follow-up
Auteur:
Heydemann, Ahlke Bieganski, Grzegorz Wachowiak, Jacek Czarnota, Jarosław Niezgoda, Adam Siemionow, Krzysztof Ziemiecka, Anna Sikorska, Maria H. Bozyk, Katarzyna Tullius, Stefan G. Siemionow, Maria